Archive for October, 2008

How To Know The Many Phases Of Allergic Asthma?

Friday, October 31st, 2008

Sad to said that you may be born with allergies because your mother unknowingly ingested food and perhaps milk to which she was allergic during her pregancy.
Babies who are nursed the 1st year are said to have stronger immune system and are less likely to be allergic than those given baby milk formula.
Therefore, with allergic as early as during pregnancy, there are many facets of asthma and each of them are …

Asthma - What To Except In The Emergency Department

Tuesday, October 28th, 2008

Emergency department care usually begins with an assessment at triage to determine the level of illness. For asthma, this includes vital signs (temperature, pulse and breathing rates, and blood pressure) and pulse oximetry, a small clip that attaches to a child’s finger or toe to …

Business Wire - IVAX’ Albuterol HFA Approvable By FDA

Friday, October 24th, 2008

Business Editors/Health/Medical Writers
MIAMI–(BUSINESS WIRE)–Dec. 1, 2003
IVAX Corporation (AMEX:IVX) (LSE:IVX.L) announced today it has received notification from the United States Food and Drug Administration (FDA) that its New Drug Application (NDA) for albuterol sulfate using a non-ozone depleting HFA (hydrofluoroalkane) propellant in a metered dose inhaler (MDI) is approvable. Albuterol is a w…

Ozone Depletion Today - IVAX Albuterol HFA Deemed ‘Approvable’ by FDA.(hydrofluoroalkane)(Brief Article)

Wednesday, October 22nd, 2008

IVAX Corporation recently announced it has received notification from the U.S. Food and Drug Administration (FDA) that the company’s new drug application for albuterol sulfate using a non-ozone depleting hydrofluoroalkane (HFA) propellant in a metered dose inhaler is “approvable.”

Most Popular
10 Jobs That Pay $3…

Business Wire - American Lung Association and Teva Partner to Educate Asthma Community about the Transition from CFC to HFA Albuterol Inhalers

Saturday, October 18th, 2008

NORTH WALES, Pa. — Teva Pharmaceutical Industries Ltd. is partnering with the American Lung Association to educate the millions of asthma sufferers transitioning to more environmentally friendly quick-relief albuterol inhalers. The effort will help people with asthma learn about the transition, understand how the inhalers differ, and help identify access options for this essential medication.
In March 2005, the Food and Drug Administration (FDA) announced a ban on albuterol …

FOCUS: Journal for Respiratory Care & Sleep Medicine - New generic albuterol medication.(PRODUCT HIGHLIGHTS)

Tuesday, October 14th, 2008

Nephron Pharmaceuticals introduces the first and only FDA approved generic version of Albuterol Sulfate Inhalation Solution, 0.042% individually foil wrapped and bar coded. Therapists or patients no longer have the e…

News: Stirling Products Launches Companion Animal Health …

Sunday, October 12th, 2008

Stirling Products Limited, an animal healthcare development and
commercialization company, today announced that it is launching its
presence into the companion animal healthcare market at the BIO2008
Annual Convention in San Diego, June 17-20, 2008. Stirling’s CEO and
Managing Director, Calvin London, will be attending the conference’s
business forum….

American Family Physician - Albuterol vs. levalbuterol for asthma treatment in children

Wednesday, October 8th, 2008

Purpose
Each month, three presenters will review an interesting journal article in a conversational manner. These articles will involve “hot topics” that affect family physicians or will “bust” commonly held medical myths. The presenters will give their opinions about the clinical value of the studies discussed. T…

Business Wire - By the Beginning of 2009, the U.S. Market for Inhaled Albuterol Mdis Will Comprise Branded Products Exclusively

Sunday, October 5th, 2008

DUBLIN, Ireland — Research and Markets (http://www.researchandmarkets.com/reports/c61112) has announced the addition of Decision Resources Inc’s new report: SPECIAL REPORT: How Will the Withdrawal of Generic Albuterol Change the U.S. Respiratory Disease Market? to their offering.
The albuterol inhaler market in the United States will soon change from low-value to significant. The only MDIs sold will be branded HFA formulations; CFC propellants will…

Business Wire - The Albuterol CFC to HFA Conversion - What is the Impact?

Saturday, October 4th, 2008

PALO ALTO, Calif. — The Healthcare Group at Frost & Sullivan is pleased to announce its Exclusive Healthcare 2007 Quarterly Analyst Briefing Presentation on pharmaceutical market to be held on Thursday, September 13, 2007 at 12:00pm CT / 1:00pm ET.
The FDA has mandated that by December 31, 2008 all CFC prope…